Bellicum Pharmaceuticals Inc (BLCM)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Richard A. Fair |
| Employees: | 7 |
| Web site: | bellicum.com |
|
3730 KIRBY DRIVE, SUITE 1200, HOUSTON, TX, 77098
(832) 384-1100
| |
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
| Date | Ratio |
|---|---|
| 2020-02-06 | 1:10 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Bellicum Pharmaceuticals, Inc. focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX-601, an autologous GoCAR-T product candidate, which is in Phase 1/2 clinical trials for the. treatment of solid tumors expressing the prostate stem cell antigen.
Please log in first to see chart